"What Does BI-RADS 3 Mean and Is It a Serious Condition for the Breast?"

Update Date: Source: Network

BI-RADS 3 Category in Breast Imaging Diagnosis

In clinical practice, BI-RADS 3 category is a classification within breast imaging diagnosis, indicating that breast nodules or masses exhibit certain radiological characteristics but have a low likelihood of malignancy, typically less than 2%. Most of these nodules are benign, such as fibroadenomas and multiple cysts, which grow slowly and do not cause severe harm to the body, thus generally not considered serious diseases.

Although BI-RADS 3 breast nodules are mostly benign with low malignant risk, their formation is closely related to endocrine disorders and increased estrogen levels, leading to abnormal proliferation of breast tissue. Despite the lack of prominent symptoms, patients should still pay close attention and adopt a comprehensive management strategy.

Regular follow-ups are crucial, with imaging examinations every 3-6 months to promptly detect any changes in the nodules. Dietary adjustments should not be overlooked, advocating a low-fat, high-fiber, and vitamin-rich dietary pattern. Maintaining a healthy lifestyle, including regular sleep patterns, moderate exercise, and a positive mindset, significantly benefits breast health. In particular, the use of estrogen-based medications should be avoided to prevent exacerbation of the condition.

For high-risk female populations, such as those with a family history of breast cancer, it is essential to actively communicate with healthcare providers to explore preventive treatments or enhanced monitoring programs, safeguarding breast health comprehensively.

Patients who discover breast nodules or masses should promptly seek medical attention for imaging examination and assessment. For BI-RADS 3 nodules, doctors typically recommend regular follow-ups and observation. If the nodules show further development or a tendency towards malignancy, further examination and corresponding treatment measures will be necessary. Patients should follow their doctors' advice and actively cooperate with treatment and management to safeguard their breast health.